Síntomas gastrointestinales como manifestación de neuromielitis óptica: un reporte de caso

Barra lateral del artículo

Contenido principal del artículo

Diego Fernando Abreo Leal
  • Biografía

    Hospital Pablo Tobón Uribe. Medellín, Colombia.

Tatiana Arroyave Peña
  • Biografía

    Hospital Pablo Tobón Uribe. Medellín, Colombia.

Juan Esteban Quiroz Álvarez
  • Biografía

    Hospital Pablo Tobón Uribe. Medellín, Colombia.

Resumen

Se presenta el caso de una mujer en la quinta década de la vida que ingresa al servicio de urgencias con manifestaciones gastrointestinales consistentes en vómito e hipo. Después de múltiples estudios e intervenciones por especialistas, se piensa en el origen central de los síntomas. Se realiza una resonancia magnética nuclear (RMN) cerebral que permite el enfoque del caso y posterior confirmación del diagnóstico de una enfermedad dentro del espectro de la neuromielitis óptica, positiva para anticuerpos anti-acuaporinas-4. El tratamiento con esteroide y anticuerpo monoclonal (Rituximab) llevan a un control adecuado de la enfermedad.

Palabras clave:
hiccups, hypothalamus, neuromyelitis, vomit hipo, hipotálamo, neuromielitis, vómito soluço, hipotálamo, neuromielite, vômito

Detalles del artículo

Referencias

Ferrán C, Pedemonte V, Turcatti E, González G. Neuromyelitis optica. Medicina. 2019; 79(Suppl 3):60-5.

Sung-Min K, Seong-Joon K, Haeng JL, Hiroshi K, Palace J, Fujihara K. Differential diagnosis of neuromyelitis optica spectrum disorders. Therapeutic Advances in Neurological Disorders. 2017; 10(7):265-89.

Mealy MA,Wingerchuk DM, Palace J, Greenberg BM, Levy M. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy. JAMA Neurol. 2014; 71:324–30.

Torres J, Pruitt A, Balcer L, Galetta S, Markowitz C, Dahodwala N. Analysis of the treatment of neuromyelitis optica. J Neurol Sci. 2015; 351:31–5.

Jarius S, Wildemann B, Paul F. Neuromyelitis optica: Clinical features, immunopathogenesis and treatment. Clinical & Experimental Immunology. 2014; 176(2):149-64.

Matiello M, Kim HJ, KimW, Brum DG, Barreira AA, Kingsbury DJ, et al. Familial neuromyelitis optica. Neurology. 2010; 75:310–5.

Jacob A, Panicker J, Lythgoe D. The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom. J Neurol. 2013; 260:2134–7.

Diaz CA, Zarco LA, Lasalvia P. Caracterización clínica, paraclínica e imaginológica de una población de pacientes colombianos con espectro de neuromielitis óptica del Hospital Universitario San Ignacio. Acta Neurol Colomb. 2019; 35(4):179-85

Bizzoco E, Lolli F, Repice AM. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol. 2009; 256:1891–8.

Sato D, Kazuo F. Atypical presentations of neuromyelitis optica. Arquivos de Neuro-Psiquiatría. 2011; 69(5):824-28.

Takahashi T, Fujihara K, Nakashima I. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre. Brain. 2007; 130:1235–43.

Weinshenker BG, Wingerchuk DM. Neuromyelitis spectrum disorders. Mayo Clin Proc. 2017;

:663–79.

Sato DK, Lana-Peixoto MA, Fujihara K, de Seze J. Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status. Brain Pathol. 2013; 23:647–60.

Marignier R, Cobo A, Vukusic S. Neuromyelitis optica and neuromyelitis optica spectrum disorders. Curr Opin Neurol. 2017; 30:208–15.

Mandler RN. Neuromyelitis optica - Devic’s syndrome, update. Autoimmun Rev. 2006; 5:537 43.

Apiwattanakul M, Popescu BF, Matiello M. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010; 68(5):757–61.

Suzuki N, Takahashi T, Aoki M. Neuromyelitis optica preceded by hyperCKemia episode. Neurology. 2010; 74:1543-5.

Jinming H, Yang M, Zhu J, Jin T. Complexity and wide range of neuromyelitis optica spectrum disorders: More than typical manifestations. Neuropsychiatric Disease and Treatment. 2017; 13:2653-60.

Rosales D, Ilya K. Common and rare manifestations of neuromyelitis optica spectrum disorder. Current Allergy and Asthma Reports. 2016; 16(6):42.

Jin X, Pei S, Liu Y, Li X. Clinical analysis of neuromyelitis optica presenting as intractable nausea, vomiting and hiccups. Int J Neurosci. 2017; 127:854-8.

Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, et al. Intractable nausea and vomiting from autoantibodies against a brain water channel . Clin Gastroenterol Hepatol. 2013; 11:240-5.

Popescu BF, Lennon VA, Parisi JE. Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications. Neurology. 2011; 76:1229-37.

Mukhyaprana PM, Agrawal U. Intractable vomiting and hiccups: An atypical presentation of neuromyelitis optica. Cureus. 2019; 11(11):e6245.

Kaloudi D, Svenningsson A, von Heijne A. [Diagnostic challenge in a man with intractable hiccups and vomiting: A case of neuromyelitis optica spectrum disorder (NMOSD)]. Lakartidningen. 2019; 116:FL4F.

Jin X, Pei S, Liu Y, Li X. Clinical analysis of neuromyelitis optica presenting as intractable nausea, vomiting and hiccups. Int J Neurosci. 2017; 127(10):854-8.

Prabhu MM, Agrawal U. Intractable vomiting and hiccups: An atypical presentation of neuromyelitis optica. Cureus. 2019; 11(11):e6245.

Zaidi SM, Mohib A, Rizvi SA, Zafar A. Vomiting in neuromyelitis optica: An atypical presentation. Cureus. 2019; 11(7):e5225.

Enweluzo C, Yarra P. Neuromyelitis optica: An often forgotten cause of intractable nausea and vomiting. Case Rep Gastroenterol. 2013; 7(2):281-6.

Biswas A, Mukherjee A. Therapy of NMO spectrum disorders. Ann Indian Acad Neurol. 2015; 18:S16–23.

Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M. Treatment of acute relapses

in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Mult Scler.

; 22:185–92.

Artículos más leídos del mismo autor/a